David John Smith - Feb 29, 2024 Form 4 Insider Report for Glimpse Group, Inc. (VRAR)

Signature
/s/ David John Smith
Stock symbol
VRAR
Transactions as of
Feb 29, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 09:55 AM
Previous filing
May 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRAR Stock Option (Right to Purchase) Disposed to Issuer $0 -64.3K -100% $0.00* 0 Feb 29, 2024 Common Stock 64.3K Direct F1, F2
transaction VRAR Stock Option (Right to Purchase) Award $0 +51.5K $0.00 51.5K Mar 1, 2024 Common Stock 51.5K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the forfeiture of vested options to purchase an aggregate of 64,349 shares of common stock ("CS") granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 4,500 shares of CS and 20,004 shares of CS granted on January 6, 2023 and September 1, 2018, respectively, with exercise prices of $7.00/share and $4.00/share, respectively, (ii) 6,668 shares of CS and 14,232 shares of CS granted on September 1, 2019 and January 1, 2020, respectively, with exercise prices of $4.00/share and $4.50/share, respectively, (iii) 1,333 shares of CS and 667 shares of CS granted on May 1, 2020 and July 1, 2020, respectively, with an exercise price of $4.50/share, (iv) 889 shares of CS and 11,556 shares of CS granted on November 1, 2020 and January 1, 2021, with an exercise price of $4.50/share, and (v) 4,500 shares of CS granted on April 1, 2023 with an exercise price of $7.00/share.
F2 The options in footnote (1) were to expire 10 years from their respective grant dates.
F3 Mr. Smith was granted options to purchase an aggregate of 51,480 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 17,160 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 17,160 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 17,160 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.